US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class III · Low risk Terminated

Buprenorphine and Naloxone Sublingual Tablets

Reason Failed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.

Teva Pharmaceuticals USA NDC 0093-5720-56 D-0983-2017
Class III · Low risk Terminated

Obagi-C Rx System C-Therapy Night Cream

Reason Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.

Valeant Pharmaceuticals North America LLC NDC 62032-222-02 D-0998-2017
Class II · Moderate risk Terminated

parodontax WHITENING

Reason Presence of Foreign Substance: possibility of the presence of metal in the product.

GSK Consumer Healthcare NDC 0135-0601-01 D-0944-2017
Class II · Moderate risk Terminated

Lactulose Solution

Reason Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.

VistaPharm, Inc. NDC 66689-038-01 D-1053-2017
Class II · Moderate risk Terminated

Lactulose Solution

Reason Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.

VistaPharm, Inc. NDC 66689-038-50 D-1052-2017
Class II · Moderate risk Terminated

Potassium PHOSphate in 5% Dextrose Injection

Reason Lack of Assurance of Sterility; media fill failure at manufacturer

PharMedium Services, Llc NDC 61553-300-11 D-0997-2017
Class II · Moderate risk Terminated

Potassium PHOSphate in 5% Dextrose Injection

Reason Lack of Assurance of Sterility; media fill failure at manufacturer

PharMedium Services, Llc NDC 61553-310-41 D-0995-2017
Class II · Moderate risk Terminated

Potassium PHOSphate in 5% Dextrose Injection

Reason Lack of Assurance of Sterility; media fill failure at manufacturer

PharMedium Services, Llc NDC 61553-299-48 D-0993-2017
Class II · Moderate risk Terminated

Potassium PHOSphate in 5% Dextrose Injection

Reason Lack of Assurance of Sterility; media fill failure at manufacturer

PharMedium Services, Llc NDC 61553-283-03 D-0989-2017
Class II · Moderate risk Terminated

Succinylcholine Chloride Injection

Reason Lack of Assurance of Sterility; media fill failure at manufacturer

PharMedium Services, Llc NDC 61553-364-65 D-0985-2017
Class II · Moderate risk Terminated

Timolol-Brimonidine-Dorzolamide-Latanoprost

Reason Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

ImprimisRx CA, Inc., dba ImprimisRx D-1133-2017
Class II · Moderate risk Terminated

Timolol-Latanoprost PF Solution

Reason Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

ImprimisRx CA, Inc., dba ImprimisRx D-1132-2017
Class II · Moderate risk Terminated

Latanoprost PF Solution

Reason Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

ImprimisRx CA, Inc., dba ImprimisRx D-1131-2017
Class II · Moderate risk Terminated

Curcumin Emulsion 10mg/ml Injection

Reason Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

ImprimisRx CA, Inc., dba ImprimisRx D-1130-2017
Class III · Low risk Terminated

Paroxetine Extended-Release Tablets USP

Reason Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study.

Lupin Pharmaceuticals Inc. D-0974-2017
Class II · Moderate risk Terminated

Potassium Phosphate

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. NDC 15082-922-25 D-0956-2017
Class II · Moderate risk Terminated

Potassium Phosphate

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. NDC 15082-924-25 D-0955-2017